The eDrugSearch Blog » Gleevec /edsblog Helping Americans Buy Prescription Drugs Online from Canada Mon, 16 Aug 2010 16:22:34 +0000 en hourly 1 http://wordpress.org/?v=3.0.1 Novartis patent bid rejected in India /edsblog/novartis-patent-bid-rejected-in-india/ /edsblog/novartis-patent-bid-rejected-in-india/#comments Tue, 07 Aug 2007 20:12:29 +0000 Cary Byrd /edsblog/novartis-patent-bid-rejected-in-india/ An Indian court has rejected Novartis’ challenge of a law that denies patent protection to drugs that are only minor improvements to earlier drugs. Novartis’ challenge came after the Indian government allowed drug companies to make generic versions of the cancer drug Gleevec.

This is great news for consumers — both because it enables more people in the Third World to have access to affordable drugs, and because it encourages companies like Novartis to focus their R&D money on real innovation, rather than wasting valuable research dollars on gaming the system to extend patents.

More from Ed at Pharmalot.

]]> /edsblog/novartis-patent-bid-rejected-in-india/feed/ 1